NPCE Insider Trading Activity and SEC Form 4 Filings
NPCE insider trading summary
Over the past 12 months, insiders at NeuroPace Inc (NPCE) reported 1 sale worth $399K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $399K.
Latest NPCE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 15, 2025 | Martha Morrell | Chief Medical Officer | Sell | $399K (25,000 @ $15.97) |
| May 14, 2025 | OrbiMed Capital GP VI LLC | 10% Owner | Sell | $542K (34,000 @ $15.94) |
| May 14, 2025 | Orbimed Advisors LLC | 10% Owner | Sell | $542K (34,000 @ $15.94) |
| May 14, 2025 | Orbimed Advisors LLC | 10% Owner | Sell | $2.1M (134,136 @ $15.83) |
| May 14, 2025 | OrbiMed Capital GP VI LLC | 10% Owner | Sell | $2.1M (134,136 @ $15.83) |
| Feb 21, 2025 | Martha Morrell | Chief Medical Officer | Sell | $1.1M (78,334 @ $13.72) |
| Feb 20, 2025 | Kck Ltd. | 10% Owner | Sell | $49.5M (5,270,845 @ $9.40) |
| Jan 30, 2025 | Martha Morrell | Chief Medical Officer | Sell | $3K (200 @ $15.00) |
| Jan 29, 2025 | Martha Morrell | Chief Medical Officer | Sell | $2K (100 @ $15.00) |
| Jan 24, 2025 | Martha Morrell | Chief Medical Officer | Sell | $48K (3,200 @ $15.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.